Catalyst Wire Dossier Catalyst Wire Dossier

AVZIVI TNJN

BEVACIZUMAB · Bio-Thera Solutions, Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVZIVI TNJN, covering 2023-12-06 to 2023-12-06. Get the full timeline:

Most recent: FDA Approved: AVZIVI TNJN — Original Application (Bio-Thera Solutions, Ltd.)

See pricing